Q3 2024 |
329 |
$1.53B |
+$29.9M |
-$54.5M |
-$24.6M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
10/18/2024, 06:40 AM |
Q2 2024 |
328 |
$1.5B |
+$20.5M |
-$24.2M |
-$3.72M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
7/16/2024, 12:26 PM |
Q1 2024 |
337 |
$1.57B |
+$393M |
-$77.4M |
+$315M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
4/19/2024, 10:46 AM |
Q4 2023 |
344 |
$1.1B |
+$12.1M |
-$73.2M |
-$61.1M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
1/16/2024, 06:08 AM |
Q3 2023 |
357 |
$1.07B |
+$107M |
-$76.7M |
+$29.9M |
GSK, MSFT, HLN, GOOGL, JPM
|
13F-HR |
10/10/2023, 07:34 AM |
Q2 2023 |
363 |
$1.05B |
+$96M |
-$24.4M |
+$71.6M |
GSK, HLN, MSFT, JPM, UNP
|
13F-HR |
7/19/2023, 09:54 AM |
Q1 2023 |
371 |
$942M |
+$2.94M |
-$259M |
-$256M |
GSK, HLN, JPM, UNP, EQT
|
13F-HR |
4/26/2023, 11:49 AM |
Q4 2022 |
396 |
$1.17B |
+$508M |
-$7.54M |
+$500M |
GSK, HLN, JPM, UNP, GOOGL
|
13F-HR |
1/18/2023, 11:05 AM |
Q3 2022 |
324 |
$600M |
+$310M |
-$386M |
-$76.4M |
GSK, HLN, JPM, UNP, GOOGL
|
13F-HR |
11/2/2022, 10:36 AM |
Q2 2022 |
299 |
$764M |
+$2.36M |
-$20.9M |
-$18.5M |
GSK, GOOGL, UNP, EEM, QQQ
|
13F-HR |
7/22/2022, 10:42 AM |
Q1 2022 |
307 |
$903M |
+$167M |
-$41M |
+$126M |
GSK, GOOGL, UNP, EEM, QQQ
|
13F-HR |
5/6/2022, 09:13 AM |
Q4 2021 |
311 |
$809M |
+$15.7M |
-$18.2M |
-$2.59M |
GSK, GOOGL, AMZN, UNP, EEM
|
13F-HR |
1/24/2022, 09:49 AM |
Q3 2021 |
310 |
$747M |
+$149M |
-$55.5M |
+$93.7M |
GSK, GOOGL, AMZN, UNP, EEM
|
13F-HR |
11/9/2021, 09:53 AM |
Q2 2021 |
298 |
$678M |
$0 |
$0 |
|
GSK, GOOGL, UNP, AMZN, EEM
|
13F-HR |
8/10/2021, 06:15 AM |